• Latest Posts

Roche’s Checkpoint Inhibitor Misfires in Late-Stage Trials

Interview 17 Apr 2017

Meet One of the Most Successful German Biotech Leaders Ever

Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor

Swiss Antibodies Recruited by the Developer of BMS’ Cancer Blockbuster

Interview 20 Mar 2017

Immuno-oncology is Overcrowded – Here is Where Startups Can Succeed

French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial

ADVERTISEMENT

French Biotech partners with Merck to Fight Tumor Resistance

Servier offers up to €1.7B for Dual Cancer Checkpoint Inhibitors

The 10 Biggest Clinical Success Stories of 2016 in European Biotech

Young Immuno-Oncology Biotechs attract Funding to Cure Metastasis

Video: Chatting with Immunocore about the Potential of Immuno-oncology

FDA and EMA review the First Therapy for a Deadly Skin Cancer

ADVERTISEMENT